Exacerbations and Their Outcomes International (EXACOS International)

CompletedOBSERVATIONAL
Enrollment

1,762

Participants

Timeline

Start Date

November 26, 2021

Primary Completion Date

November 30, 2022

Study Completion Date

November 30, 2022

Conditions
Chronic Obstructive Pulmonary Disease
Trial Locations (21)

220

Research Site, New Taipei City

333

Research Site, Taoyuan

11217

Research Site, Taipei

40705

Research Site, Taichung

44670

Research Site, Guadalajara

50006

Research Site, Changhua

72450

Research Site, Puebla City

80756

Research Site, Kaohsiung City

100225

Research Site, Taipei

119991

Research Site, Moscow

185019

Research Site, Petrozavodsk

196247

Research Site, Saint Petersburg

199106

Research Site, Saint Petersburg

394066

Research Site, Voronezh

404332

Research Site, Taichung

454021

Research Site, Chelyabinsk

620109

Research Site, Yekaterinburg

644005

Research Site, Omsk

660037

Research Site, Krasnoyarsk

675000

Research Site, Blagoveshchensk

7580023

Research Site, Santiago

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY